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Neurocognitive functioning following preeclampsia
and eclampsia: a long-term follow-up study
Ineke Rixt Postma, BSc; Anke Bouma, PhD; Iefke Froukje Ankersmit, MSc; Gerda Geertruida Zeeman, MD, PhD
OBJECTIVE: Women who suffered preeclampsia and eclampsia may RESULTS: Both preeclamptic and eclamptic women performed worse
report subjective cognitive difficulties in daily life, the interpretation of
which is cumbersome, because these are affected by emotional fac-
tors. Previous studies only included preeclamptic women investigated
shortly after pregnancy. We aimed to determine whether these sub-
jective reports of cognitive difficulty could be interpreted as reflecting
objective cognitive dysfunction. Therefore, cognitive functioning was
assessed using standardized neurocognitive tests in both preeclamptic
and eclamptic women several years following the index pregnancy.
STUDY DESIGN: Forty-six formerly eclamptic, 51 formerly preeclamptic,
and 48 control women who had normotensive pregnancies, age-
matched, participated in this study. Average elapsed time since index
pregnancy was 7 years. Neurocognitive tests were divided into 6 do-
mains; visual perception, motor functions, working memory, long-term
memory, attention, and executive functioning. Subjective cognitive
functioning was measured by the Cognitive Failures Questionnaire and
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other domains. They scored worse on the Cognitive Failures Ques-
tionnaire (P< .01), the Hospital Anxiety and Depression Scale anxiety
(P < .01), and depression (P < .05) subscales.
CONCLUSION: Women who suffered eclampsia and/or preeclamp-
sia demonstrate no objective cognitive impairment as compared
with controls. Contrary to the well-structured test setting, both
groups do report more cognitive failures, which are thought to
reflect neurocognitive dysfunction in complex, stressful daily-life
situations. Such report of cognitive failures may be compounded
by anxiety and depression. Future studies should focus on the
relationship of neurocognitive functioning with structural cerebral
abnormalities.
Key words: anxiety and depression, cognitive complaints, eclampsia,
neurocognitive functioning, preeclampsiaCite this article as: Postma IR, Bouma A, Ankersmit IF, et al. Neurocognitive functioning following preeclampsia and eclampsia: a long-term follow-up study.
Am J Obstet Gynecol 2014;211:37.e1-9.omen who suffered preeclamp-W sia and/or eclampsia report co-
gnitive problems years after the index
pregnancy.1,2Although the actual preva-
lence of subjective cognitive difﬁculties is
unknown, they appear to be related to
memory, concentration, and vision-
related tasks of everyday life.1-4
In general, the validity of such subjec-
tive reports of cognitive functioning re-
mains controversial, because they are also
strongly inﬂuenced by noncognitive fac-
tors such as symptoms of anxiety and
depression.5,6 Preeclamptic women may
exhibit such psychopathology after theexperience of a complicated pregnancy.7-9
Alternatively, women who suffered (pre)
eclampsia may have structural brain ab-
normalities, such as white matter lesions,
potentially causing neurocognitive
dysfunction.10-14
Two small studies evaluated neuro-
cognitive test performance in pre-
eclamptic (but not eclamptic) women
within 1.5 years after the index pregnancy
and found impairment on some, but not
on all cognitive tests.8,15 Another small
study found no evidence for impaired
executive functioning and sustained
attention.16ter Groningen
l Neuropsychology
herlands.
ds organization for
016/j.ajog.2014.01.042
JULY 2014 AmeBecause longer follow-up of neuro-
cognitive performance is lacking, we
aimed to study cognitive functioning in a
relatively large group of women who had
preeclampsia and eclampsia using stan-
dardized neurocognitive tests and relate
this to self-reported cognitive dysfunction
and measures of anxiety and depression.
We hypothesized that eclamptic women
will demonstrate worse performance
compared with preeclamptic women, and
that both groups would perform worse
than controls. Because other studies fo-
cused on more limited subdomains of
cognitive functioning, we chose to cover a
broader range of neurocognitive functions
including tasks associated with the pos-
terior brain areas (eg, visual functioning
tasks) as well as the frontal brain areas (eg,
attention and executive functioning).
MATERIALS AND METHODS
Participants
All eclamptic, preeclamptic, and control
women with normotensive pregnancies,
who were enrolled in a previous follow-rican Journal of Obstetrics& Gynecology 37.e1
Research Obstetrics www.AJOG.orgup study, received a new invitation.10,11
Recruitment and selection criteria have
been published previously.10,11,14 Ec-
lampsia and preeclampsia were deﬁned
according to international criteria.17
Preeclampsia was deﬁned as de novo hy-
pertension after 20 weeks’ gestation and
properly documented proteinuria. Ec-
lampsia was deﬁned as new onset of
seizures in women with preeclampsia.
Early-onset (pre)eclampsiawas deﬁned as
indicated delivery <34 weeks’ gestational
age. Medical records were reviewed for
accurateness of diagnosis and to extract
clinical and demographic characteristics.
This project was approved by the Uni-
versity Medical Center Groningen Insti-
tutional Review Board and all women
signed informed consent. Measurements
were performed between November 2008
and January 2012.
Exclusion criteria were epilepsy, a
known cerebrovascular accident, de-
myelinating disorders, intracranial in-
fections, a history of any cranial
neurosurgic procedure, the inability to
understand Dutch, or pregnancy at the
moment of testing. Women who indi-
cated the presence of a mood disorderTABLE 1
Overview of participant characteristi
Characteristic
Age, y
White, n (%)
Elapsed time since index pregnancy, y
Birthweight, g
EGA at delivery, wk
SGA <10th percentile, n (%)
Early-onset (pre)eclampsia <34 wk, n (%)
Nulliparous at index pregnancy, n (%)
Level of education, n (%)
Average
High
DART IQ
Antidepressants, n (%)
Results are expressed as mean (SD), median (min-max), or num
DART, Dutch Adult Reading Test; EGA, estimated gestational ag
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37.e2 American Journal of Obstetrics& Gynecolowere not excluded. For all women,
elapsed time since the index pregnancy
had to be at least 12 months. Of the 63
eclamptic women who participated in
the previous studies,10,11,14 48 (76%)
could be contacted again and were
willing to participate in the present
study. Of the 74 preeclamptic and 75
parous control participants participating
in previous studies,10,11,14 respectively,
47 (64%) and 43 (57%) could be con-
tacted again and were willing to partici-
pate. Four preeclamptic women who
delivered in other hospitals and who had
heard about the study requested to
participate in the current study, whichwas
allowed. Six additional control partici-
pants were included. During the study, 2
eclamptic women were excluded as they
showed signs of malingering or un-
derachievement. This was evaluated by
the Amsterdam Short-Term Memory
(ASTM) test, a symptom validation test
presented as a short-term memory
task.18,19 The ASTM test is a valid,
standardized, and widely used test to
indicate malingering. Excluding these
women did not signiﬁcantly alter the
results. One control was excludedcs
Eclampsia
(n[ 46)
Preeclampsia
(n[ 51)
39 (6.5) 39 (6.7)
44 (96) 51 (100)
8 (2-20) 6 (1-18)
1310 (300-4440) 1960 (310-4470)
32 (22-42þ1) 34þ4 (26þ2-41)
14 (30) 20 (39)
28 (61) 24 (47)
40 (87) 34 (67)
18 (39) 24 (47)
28 (61) 27 (54)
99 (11.1) 98 (10.7)
0 (0) 6 (12)
ber (percentage).
e; SGA, small for gestational age.
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gy JULY 2014because she had professional knowl-
edge of the neurocognitive tasks. Forty-
six eclamptic women, 51 preeclamptic
women, and 48 controls remained
available for analysis.
Age and level of education were
similar in the 3 groups (Table 1). Edu-
cation level was categorized according to
the system of Verhage as described by
Bouma19 (1 being the lowest [less than
primary school], and 7 the highest [ac-
ademic degree, such as bachelor/mas-
ter]). None of the womenwere in the low
education group (category 1 or 2).
Average was deﬁned as category 3-5 and
as high as category 6-7. The Dutch Adult
Reading Test (DART; Dutch version of
the National Adult Reading Test) was
used to determine premorbid intelli-
gence.19,20 The DART is a valid, stan-
dardized test based on the assumptions
that reading ability (of irregular words)
is relatively independent of brain disor-
ders, and that it is a strong predictor of
intelligence in the normal popula-
tion.19,20 No signiﬁcant difference was
found between the groups. One partici-
pant had sufﬁcient knowledge of the
Dutch language to fulﬁl the tasks, but theControls
(n[ 48) P value
40 (7.3) .56
46 (96) .40
6 (1-27) .02
3600 (2210-4620) < .01
40 (36þ2-40þ2) < .01
4 (8) < .01
21 (44) < .01
18 (38) .59
30 (63)
99 (10.5) .87
2 (4) .99
www.AJOG.org Obstetrics ResearchDART could not be administered. Ano-
ther participant was unable to complete
the DART because of dyslexia. The
population in the northern part of the
Netherlands is predominantly white, as
was our study population.
Cognitive Failures Questionnaire
(subjective cognitive functioning)
The Cognitive Failures Questionnaire
(CFQ) evaluates the number of errors
committed in the completion of daily
tasks.21 Subjects were asked to complete
the questionnaire based on their expe-
riences in the past 6 months. The CFQ
consists of 25 items, each scored on a
5-point scale (0-4). The total scale ranges
from 0e100, with higher scores indi-
cating more cognitive failures. A cutoff
point for the CFQ total score based on
the Dutch population was set at 44.22
Three subscales, forgetfulness (8 items),
distractibility (8 items), and false trig-
gering (8 items) were derived.23 Forget-
fulness is deﬁned as a tendency to let go
from one’s mind something known or
planned. It includes questions like “Do
you read something and ﬁnd you haven’t
been thinking about it and must read it
again?” Distractibility pertains to social
situations or interactions with other
people such as being absentminded or
easily disturbed and contains questions
like “Do you fail to hear people speaking
to you when you are doing something
else?” False triggering pertains to inter-
rupted processing of sequences of co-
gnitive and motor actions and contains
questions like “Do you fail to notice
signposts on the road?”
Neuropsychologic tests (objective
measures of cognitive functioning)
Participants completed a battery of
16 standardized, reliable, and valid
neuropsychologic tests divided into 6
cognitive domains.19,24 These tests are
sensitive to cognitive impairment and
have been validated in different pop-
ulations (normal subjects, neurologic,
and psychiatric patients) using different
methods (eg, correlational and factor-
analytic studies as well as neuroimaging
studies). Each cognitive domain con-
sisted of verbal and nonverbal tasks.
Tests were administered in a ﬁxedsequence according to standardized in-
structions for each measure by 2 ad-
vanced doctoral students who were
well-trained by a neuropsychologist.
The battery took approximately 150
minutes to complete (with a 10-minute
break halfway). Measures were scored
in a standardized fashion outlined in the
administration manual of each test.
Visual perception
Visual perception was measured using
a Dutch Incomplete Figures Test
(GIT-2).25 Visual processing speed was
measured using the Digit Symbol Cod-
ing (WAIS-III-NL) test, Symbol Search
(WAIS-III-NL)26 test and the Dutch
Stroop Color-Word Test part 1 (word
reading) and part 2 (color naming).27
Motor functions
Visuomotor speed was measured using
the Grooved Pegboard Test28 for both
the dominant and nondominant hand
and the Trail Making Test part 5 (Motor
Speed; Delis-Kaplan Executive Function
System [D-KEFS]).29
Working memory
Visuospatial working memory (WM)
was assessed using the Corsi Block-
Tapping Test (backward and forward
version), a total product score was
derived from the number of correct se-
quences and the block span.30 The task is
considered a nonverbal analog to Digit
Span (WAIS-III-NL), which was used to
measure verbal WM together with the
Letter-Number Sequencing Test (WAIS-
III-NL).26
Long-term memory
Visuospatial long-term memory (LTM)
was assessed by the Dutch version of the
Location Learning Test (administration
procedure II).31 A total score was
derived. Verbal LTM was measured by
the Dutch version of the Rey Auditory
Verbal Learning Test32 in which subjects
had to learn 15 words in 5 successive
trials. A total score was derived.
Attention
Part 1 (visual scanning), part 2 (number
sequencing), and part 3 (letter
sequencing) of the Trail Making TestJULY 2014 Ame(D-KEFS) were used to measure atten-
tion.29 These conditions were designed to
quantify key component skills that are
required for performing the Number-
Letter Switching condition described
below.
Executive functioning
Inhibitory control was assessed by part
3 (inhibitory control) of the Dutch
Stroop Color-Word Test.27 Part 4 of the
Trail Making Test (Number-letter
switching) is similar to ‘Part B’ of the
original Trail Making Test.29,33 It mea-
sures divided attention and cognitive
ﬂexibility. Fluency tasks consisted of the
Verbal Fluency Test (animals and pro-
fessions) and the Figure Fluency Test
(Dutch version of the Ruff Figure Fluency
Test) for visuospatial ﬂuency.34,35 Plan-
ning was measured by the Tower Test
(D-KEFS).29
The Hospital Anxiety and Depression
Scale
The Hospital Anxiety and Depression
Scale (HADS) is a self-report screening
scale that entails 14 items scored on a
4-point scale (0-3).36 Items were divided
into 2 subscales: anxiety and depression,
each with a maximum score of 21, with
higher scores indicating more symptoms.
Statistical analyses
Statistical analysis was performed using
IBM Statistical Package for the Social
Sciences version 20 for Windows (IBM
Inc, Chicago, IL). Raw test scores were
used. Data were checked for normalcy of
distribution using distribution curves,
Shapiro-Wilk test and Levene’s test
for homogeneity of variance. Small de-
viations from a normal distribution
because of an outlier were accepted. For
measures (Trail Making Test) that were
non-normally distributed, logarithmic
transformation was used. There were
no differences in outcomes between
these transformations and nonpara-
metric tests. Patient characteristics were
analyzed using Kruskall-Wallis test for
nonnormally distributed data and c2 test
for categoric data. Antidepressant use
was analyzed using Fisher’s exact test
comparing both patient groups with
controls. Single imputation was used torican Journal of Obstetrics& Gynecology 37.e3
Research Obstetrics www.AJOG.orgreplace 2 missing values in the ques-
tionnaire (because of a missed question)
and 2 missing values (because of missing
test forms) in the tests using estimated
means for the whole group. Mean and
median values were calculated before
and after imputation to ensure the
absence of differences. CFQ and HADS
outcomes were analyzed using 1-way
ANOVA, corrected for elapsed time
since index pregnancy, and c2 test for
cut-off scores. Signiﬁcant outcomes were
further analyzed using a Helmert’s
contrast (which compares a level with
the mean of subsequent levels, ie, con-
trols vs preeclampsia/eclampsia and
preeclampsia vs eclampsia), because we
hypothesized that both the preeclamptic
and the eclamptic group would score
worse than controls, and the eclamptic
group was expected to score worse
compared with the preeclamptic group.
Pearson’s correlation coefﬁcient was
used to describe the relationship be-
tween the CFQ and the HADS scores.
Multivariate analysis using MANOVA
was performed on the different neuro-
cognitive test domains, corrected for
elapsed time since index pregnancy.
Signiﬁcant MANOVA results were sub-
sequently tested using univariate analysis
(ANOVA). Effect sizes (partial h2) were
calculated to estimate the strength of
signiﬁcant effects between groups.37 An
effect size of partial h2¼ .01 was deﬁned
as small, h2 ¼ .06 as medium and h2 ¼
.14 as large.37 To detect a medium effect
size of h2 ¼ .06 on the multivariateTABLE 2
Questionnaires
Questionnaire
Cognitive Failures Questionnaire (CFQ)
Hospital Anxiety and Depression Scale (HADS)
Results are expressed as mean (SD), F:1-way analysis of varian
Postma. Neurocognitive functioning following (pre)eclamps
37.e4 American Journal of Obstetrics& Gynecoloanalysis of the test domains for 3 groups,
with a power of .80 and alpha of .05,
inclusion of 33 (2 test measures) to 45
women (5 test measures) in each gr-
oup was needed.38 Multivariable linear
regression analyses with backward step-
wise inclusion with test outcomes as the
dependent variables were performed
with group (controls vs preeclampsia
and eclampsia), subjective cognitive
failures (CFQ) and anxiety/depression
(HADS) total score as predictors. We
checked for the effect of elapsed time by
adding this factor as predictor; however,
elapsed time did not signiﬁcantly change
the outcomes of the other predictors.
Differences were considered statistically
signiﬁcant at P < .05.RESULTS
Participants
In total, 46 eclamptic women, 51 pre-
eclamptic women, and 48 controls were
available for analysis. As shown in Ta-
ble 1 and as expected, there was a sig-
niﬁcant difference in gestational age at
delivery, birthweight, and the number of
small for gestational age children be-
tween the groups. Elapsed time since
index pregnancy was slightly longer
in the eclamptic group compared with
the preeclamptic group and controls.
Because women with early-onset (pre)
eclampsia did not show different results
compared with women with late-onset
(pre)eclampsia, results for this sub-
group are not separately discussed.Measure
Eclampsia
(n[ 46)
Preeclampsia
(n[ 51)
Co
(n
Total score 43 (16.4) 47 (15.8) 36
Forgetfulness 16 (5.8) 18 (6.1) 13
Distractibility 14 (5.8) 15 (5.8) 12
False triggering 12 (5.2) 13 (5.0) 9
Total score 12 (6.6) 11 (5.8) 8
Anxiety 7 (3.8) 6 (3.4) 5
Depression 5 (3.5) 4 (3.4) 3
ce test statistics of between-group effect.
ia. Am J Obstet Gynecol 2014.
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(subjective cognitive functioning)
When comparing the 3 groups, signiﬁ-
cant differences were found for the
CFQ total score and the subscales
forgetfulness, distractibility, and false
triggering (Table 2). Using Helmert
contrast, scores were signiﬁcantly worse
for preeclamptic and eclamptic women
vs controls (P < .01), but not between
preeclamptic and eclamptic women. The
effect size statistics indicate moderate
effects. As shown in the Figure, signiﬁ-
cantly more preeclamptic and eclamptic
women compared with controls scored a
considerable number of cognitive fail-
ures; 24 (52%), 35 (69%), and 8 (17%),
respectively (P<.001). Cronbach’s alpha
for the CFQ total score was 0.93, 0.86 for
the subscale forgetfulness, 0.84 for
distractibility, and 0.83 for false trig-
gering, indicating good reliability.Anxiety and depression
Signiﬁcant differences were found for
the HADS total score, anxiety, and
depression subscales, as shown in Ta-
ble 2. Using Helmert contrast, eclamptic
and preeclamptic women had similar
scores, but signiﬁcantly worse compared
with controls (P < .01). The effect size
statistics indicate moderate effects.
Cronbach’s alpha was .81 for the HADS
anxiety subscale and .80 for the depres-
sion subscale. Anxiety and depression
subscales were strongly correlated (.62).ntrols
[ 48) F (2,142)
Effect size
(partial h2) P value
(11.0) 6.91 0.089 < .001
(4.1) 8.37 0.104 < .001
(3.6) 4.34 0.059 .01
(3.9) 7.40 0.095 < .001
(5.5) 6.20 0.081 < .005
(3.1) 6.08 0.077 < .005
(2.9) 3.87 0.054 .02
FIGURE
Percentage of participants with
cognitive failures
Percentage of formerly preeclamptic and
eclamptic women and controls with high
cognitive failures questionnaire (CFQ) score
(cutoff value of 44). c2 (2, n ¼ 145) ¼ 27.8,
P  .001.
Postma. Neurocognitive functioning following (pre)
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Multivariate analysis of neuropsycho-
logic test domains only revealed a
signiﬁcant result for motor functions
(P < .05) (Table 3) because of a signiﬁ-
cant difference in visuomotor speed
measured by the Trail Making Test part 5
(D-KEFS) (P < .001). The effect size
statistics indicate small effects except for
a medium effect in visuomotor speed.
Further analysis of visuomotor speed
using Helmert contrast showed that
eclamptic women scored worse than
preeclamptic women (P < .05) and that
both patient groups scored worse
compared with controls (P < .01).
Relationship between CFQ and HADS
Signiﬁcant correlations between the
CFQ total score and the HADS anxiety
(0.37) and depression (0.54) scores were
found in the total group of participants
(P < .05 for all coefﬁcients).
Multivariable regression analysis
Multivariable linear regression analyses
with backward stepwise inclusion with
test outcomes as the dependent variables
were performed with group (controls vs
preeclampsia and eclampsia), subjectivecognitive failures (CFQ), and anxiety/
depression (HADS) total score as pre-
dictors. Elapsed time since index preg-
nancy did not signiﬁcantly change the
outcomes of the other predictors. We
found that CFQ score was associated
with WAIS-III Symbol Search (b  .22,
P< .01), Trail Making Test part 1 (b .21,
P ¼ .01), Grooved Pegboard score
nondominant hand (b .20, P ¼ .02),
Dutch Incomplete Figures Test (b .22,
P ¼ .02), Stroop Color-Word Test part 2
(b .17, P ¼ .04) and part 3 (b .24, P ¼
.003), and the Tower Test (b .18, P¼.06).
HADS total score was associated with the
Corsi Block-Tapping Test (b  .17, P ¼
.04), Dutch Incomplete Figures Test
(b .29, P¼ .003), Tower Test (b.27,
P ¼ .004), and the WAIS-III Letter-
Number Sequencing Test (b  .23, P ¼
.006). Group (controls vs preeclampsia
and eclampsia) was not signiﬁcantly
associated with any of the tests, meaning
that women with (pre) eclampsia scored
similar to controls, but for the Trail
Making Test part 5 (b .26, P ¼ .001), as
was shown previously in themultivariate
analyses (MANOVA).
COMMENT
This study aimed to assess cognitive
functioning using standardized neuro-
cognitive tests in a relatively large group
of both formerly preeclamptic and
eclamptic women with an average
follow-up of 7 years. Aside from minor
slowing in motor speed, no differences
were seen in objective measures of visual
perception, working memory, long-term
memory, attention, and executive func-
tioning as compared with controls. Pre-
eclamptic as well as eclamptic women
reported signiﬁcantly more cognitive
failures in daily life and scored signiﬁ-
cantly higher for anxiety and depression,
factors that were associated with some,
but not all neurocognitive tests. There
was no effect of early-onset (pre)
eclampsia.
Objective cognitive functioning was
the primary outcome of this study. No
objective cognitive impairment besides
a slightly slower visuomotor speed
was found in (pre)eclamptic women
compared with controls. Women with
eclampsia did not demonstrate worseJULY 2014 Ameperformance than preeclamptic women.
Our ﬁndings are consistent with our
previous study assessing executive func-
tioning and sustained attention in
formerly (pre)eclamptic women.16 Small
studies, at short-term follow-up (within
1.5 years) and only in preeclamptic
women, did not show impaired perfor-
mance on the majority of neurocognitive
tests, except for a signiﬁcantly lower
score on an auditory-verbal memory
task,15 on the Digit Symbol Coding Test
(WAIS-III) and the Paced Auditory Se-
rial Addition Test (divided attention),
which were explained by a difference in
posttraumatic stress symptoms.8
The present study found no differences
in neurocognitive test results, although
there was a difference in CFQ score, a
measure of self-reported cognitive fail-
ures representing daily life conditions. A
possible explanation for this lack of
agreement between objective neuro-
cognitive tests and subjective cognitive
failures is that subtle cognitive differences
between (pre)eclamptic women and
controls may not come to surface in a
well-structured test setting. Such test
setting is usually quiet with few distrac-
tions, there are clear time points for task
initiation and completion, and the sub-
ject is asked to complete one task at a
time. This is in contrast with daily-life
challenges, which are usually unstruc-
tured with numerous distractions, all of
which require signiﬁcant cognitive ﬂexi-
bility as well as cognitive self-evaluation
and executive control of behavior.39-42
The CFQwas developed as a valid self-
report instrument to measure the ten-
dency to make mistakes in everyday life.
In this study, the CFQ score did show an
association with scores on tests mea-
suring visual perception, visuomotor
speed, attention and executive func-
tioning, which suggests that the CFQ is
indeed related to objective cognitive
functioning. On the other hand, we
found that the CFQ strongly relates to
anxiety and depression. Anxiety and
depressionwere present to a larger extent
in (pre)eclamptic women as compared
with controls. In the literature, executive
functioning, or the control of complex,
goal-directed behavior is the cognitive
ability, which is most susceptible torican Journal of Obstetrics& Gynecology 37.e5
TABLE 3
Multivariate analysis of cognitive domains of neurocognitive tests
Cognitive
domain Function Test Measure
Eclampsia
(n[ 46)
Preeclampsia
(n[ 51)
Controls
(n[ 48)
Effect size
(partial h2) F (2,14) P value
Visual
perception
0.025 0.72a .70
Perceptual closure Dutch Incomplete
Figures Test (GIT-2)
Total score (accuracy) 13 (3.2) 13 (2.7) 13 (3.0)
Visual perceptual
speed
Digit Symbol Coding
(WAIS-III-NL)
Total score (accuracy) 81 (15.2) 83 (11.5) 81 (13.2)
Symbol Search (WAIS-III-NL) Total score (accuracy) 36 (6.8) 38 (6.4) 38 (7.3)
Stroop Color-Word Test Part 1: word reading (time) 44 (7.9) 45 (8.6) 42 (7.9)
Part 2: color naming (time) 55 (9.5) 55 (10.3) 54 (8.3)
Motor
functions
0.051 2.53a .02
Visuomotor speed Grooved Pegboard Score dominant hand (time) 66 (10.1) 66 (9.2) 64 (8.5) 0.45 .64
Score non-dominant hand (time) 74 (9.8) 73 (12.0) 72 (12.5) 0.11 .89
Trail Making Test (D-KEFS) Part 5: motor speed (time) 26 (1.5) 22 (1.3) 20 (1.3) 7.22 < .001
WM 0.015 0.73a .63
Visuospatial WM Corsi Block-tapping Test Total product score (accuracy) 97 (25) 101 (30) 108 (26)
Verbal WM Digit Span (WAIS-III-NL) Total score (accuracy) 15 (3.0) 15 (3.3) 15 (3.7)
Letter-Number Sequencing
(WAIS-III-NL)
Total score (accuracy) 10 (1.4) 10 (2.0) 11 (2.2)
LTM 0.015 1.08a .37
Visuospatial LTM Location Learning test Total score (accuracy) 16 (10.5) 18 (16.3) 15 (12.9)
Verbal LTM 15-word Learning test Total score (accuracy) 48 (7.8) 46 (7.0) 47 (8.4)
Attention 0.012 0.54a .77
Visual scanning Trail Making test (D-KEFS) Part 1: visual scanning (time) 18 (1.3) 19 (1.2) 19 (1.4)
Visual scanning and
sequencing
Trail Making test (D-KEFS) Part 2: number sequencing (time) 28 (1.4) 28 (1.3) 27 (1.4)
Part 3: letter sequencing (time) 27 (1.3) 26 (1.2) 25 (1.4)
Postma. Neurocognitive functioning following (pre)eclampsia. Am J Obstet Gynecol 2014. (continued)
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JULY 2014 Amestress.39-42 As a consequence, women
with (pre)eclampsia who indicate more
anxiety and more depressive symptoms
may therefore be more vulnerable for
cognitive failures in complex, and
perhaps more stressful daily life condi-
tions compared with controls.43 The
prevalence of posttraumatic stress dis-
order seems to be increased following
a preeclamptic pregnancy, even after
several years.44-46 Moreover, anxiety and
depression in women who had (pre)
eclampsia may be a cause, rather than a
consequence of experiencing long-
lasting cognitive failures in daily life. It
is possible that symptoms of anxiety and
depression were already present before
the index pregnancy, but these were not
speciﬁcally asked for when including
patients into the study. Both depression
and anxiety in early pregnancy seem
to be associated with the subsequent
development of preeclampsia (odds-
ratio of 2.5 and 3.2, respectively).47
The precise biochemical mechanism
behind this course of events remains
speculative: distress conditions during
pregnancy may directly change the
hypothalamic-pituitary axis (HPA) re-
sulting in increased cortisol levels and
concomitant changes in cellular immu-
nity, associated with hypertension and
endothelial dysfunction.48
Alternatively, women who had ec-
lampsia or preeclampsia more often
demonstrate cerebral whitematter lesions
on long-term follow-up MRI compared
with parous control women.10,11 One
could expect that the presence of such
lesions may inﬂuence both subjective and
objective cognitive functioning. However,
nonobstetric studies reveal that subjective
complaints at a relatively young age
appear to be related to cerebral structural
abnormalities, such as white matter le-
sions, and cognitive decline in later
life.5,6,49 Therefore, it cannot be excluded
that the cognitive complaints found in
this study are related to white matter le-
sions, even in patients who did not show
objective cognitive disturbances.
The main strength of this study is that
it is, to date, the largest study with well-
deﬁned groups of formerly preeclamp-
tic and eclamptic women to report both
subjective cognitive functioning andrican Journal of Obstetrics& Gynecology 37.e7
Research Obstetrics www.AJOG.orgstandard neurocognitive test results in
the long-term and relate these to
emotional factors such as anxiety and
depression. There are several limitations
to this study, one of which is the lack of
prepregnancy information on neuro-
cognitive functioning. In view of the rare
incidence of eclampsia, a prospective
study design is not feasible. Second,
approximately 70% of the women who
participated in the study of Aukes
et al10,11 could be contacted again and
were willing to participate in the study
now reported that may have given rise to
selection bias. However, most nonpar-
ticipating women could not be contacted
because of change of address and/or
phone number. Other nonparticipating
women mentioned the time and travel
burden as the main reason not to
participate, although some declined
because of fear of confrontation with the
traumatic experience of their compli-
cated pregnancy. Third, the wide range
in elapsed time since index pregnancy
reﬂects the rare incidence of eclampsia.
Despite careful matching, elapsed time
since index pregnancy was slightly
longer in eclamptic women, however,
controlling for elapsed time did not
signiﬁcantly alter the results. Fourth,
the effect of subsequent pregnancies
following the index pregnancy can not
be excluded. Nine women had pre-
eclampsia during a subsequent preg-
nancy. Last, it was not possible to reliably
recruit more previously eclamptic
women into this study. In the context of
the rare incidence of eclampsia this
represents a sizeable study showing re-
sults that are clinically important.
In summary, formerly preeclamptic
and eclamptic women do not show clear
neurocognitive impairment years after
the index pregnancy but for minor
slowing in motor speed. They express
cognitive failures that are thought to
reﬂect neurocognitive dysfunction in
complex, and stressful daily-life situa-
tions. Such report of cognitive failures
may be compounded by symptoms of
anxiety and depression. Indeed, the CFQ
may be interpreted as a measure of ex-
ecutive control of behavior, in which
people with anxiety and depression
experience cognitive failures mainly in37.e8 American Journal of Obstetrics& Gynecolocomplex and stressful daily life events.40
In this scheme high levels of stress hor-
mones seem detrimental for executive
control and make a person susceptible
for cognitive failures.41 Moreover, they
might be an indicator for development
of cognitive dysfunction at older age.
Either way, subjective cognitive difﬁ-
culties in such a young cohort of women
should be taken seriously and these
women deserve long-term follow-up.
Future studies should focus on the
relationship between subjective and
objective neurocognitive functioning,
symptoms of anxiety and depression and
brain white matter lesions. Follow-up
studies (ie, 20-30 years) would provide
insight whether there is a relationship
between (pre)eclampsia and subjective
cognitive difﬁculties earlier in life and
dementia and cerebrovascular disease
later in life. -
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